| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5584410 | Experimental and Molecular Pathology | 2017 | 11 Pages |
Abstract
IGFBP-5, IGF-1 and TGF-β1 in the type II AECs play a key role in lung injury caused by bleomycin and pioglitazone attenuates the lung injury/fibrosis by restoring IGFBP-5 and IGF-1 and decreasing TGF-β1 expressions in the type II AECs.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Clinical Biochemistry
Authors
Lakshmi Kanth Kotarkonda, Ritu Kulshrestha, Krishnan Ravi,